Cargando…

Immunity to glycan α-Gal and possibilities for the control of COVID-19

Detalles Bibliográficos
Autores principales:	de la Fuente, José, Gortázar, Christian, Cabezas-Cruz, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735019/ https://www.ncbi.nlm.nih.gov/pubmed/33307805 http://dx.doi.org/10.2217/imt-2020-0247

Ejemplares similares

Immunity to α-Gal: The Opportunity for Malaria and Tuberculosis Control
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2017)

Immunity to α-Gal: Toward a Single-Antigen Pan-Vaccine To Control Major Infectious Diseases
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2017)

Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2017)

The α-Gal Syndrome and Potential Mechanisms
por: Román-Carrasco, Patricia, et al.
Publicado: (2021)

A dataset for the analysis of antibody response to glycan alpha-Gal in individuals with immune-mediated disorders
por: de la Fuente, José, et al.
Publicado: (2021)

Probiotic Bacteria with High Alpha-Gal Content Protect Zebrafish against Mycobacteriosis
por: Pacheco, Iván, et al.
Publicado: (2021)

Vaccination with Alpha-Gal Protects Against Mycobacterial Infection in the Zebrafish Model of Tuberculosis
por: Pacheco, Iván, et al.
Publicado: (2020)

Environmental and Molecular Drivers of the α-Gal Syndrome
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2019)

The alpha-Gal syndrome: new insights into the tick-host conflict and cooperation
por: de la Fuente, José, et al.
Publicado: (2019)

Tick Bites Induce Anti-α-Gal Antibodies in Dogs
por: Hodžić, Adnan, et al.
Publicado: (2019)

N-GAL: Diagnosing AKI as soon as possible
por: Ronco, Claudio
Publicado: (2007)

Functional characterization of α-Gal producing lactic acid bacteria with potential probiotic properties
por: Bamgbose, Timothy, et al.
Publicado: (2022)

Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes
por: Galili, Uri
Publicado: (2020)

The sound of host-SARS-CoV-2 molecular interactions
por: de la Fuente, José, et al.
Publicado: (2021)

Will we ever eradicate animal tuberculosis?
por: Gortázar, Christian, et al.
Publicado: (2023)

Tick galactosyltransferases are involved in α-Gal synthesis and play a role during Anaplasma phagocytophilum infection and Ixodes scapularis tick vector development
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2018)

Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies
por: Hatfield, Grayson, et al.
Publicado: (2023)

Gut Microbiota Abrogates Anti-α-Gal IgA Response in Lungs and Protects against Experimental Aspergillus Infection in Poultry
por: Mateos-Hernández, Lourdes, et al.
Publicado: (2020)

COVID-19 is likely to impact animal health
por: Gortázar, Christian, et al.
Publicado: (2020)

Monitoring the Subolesin Vaccine Field Trial for Safer Control of Cattle Ticks Amidst Increasing Acaricide Resistance in Uganda
por: Kabi, Fredrick, et al.
Publicado: (2022)

The Gal/GalNac lectin as a possible acetylcholine receptor in Entamoeba histolytica
por: Pacheco-Sánchez, Marisol, et al.
Publicado: (2023)

Infection with Toxocara canis Inhibits the Production of IgE Antibodies to α-Gal in Humans: Towards a Conceptual Framework of the Hygiene Hypothesis?
por: Hodžić, Adnan, et al.
Publicado: (2020)

Evidence for glycosylation as a regulator of the pigmentary system: key roles of sialyl(α2-6)gal/GalNAc-terminated glycans in melanin synthesis and transfer
por: Diwakar, Ganesh, et al.
Publicado: (2015)

Chemoenzymatic modular assembly of O-GalNAc glycans for functional glycomics
por: Wang, Shuaishuai, et al.
Publicado: (2021)

Metastases: the glycan connection
por: Couldrey, Christine, et al.
Publicado: (2000)

Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies
por: Galili, Uri
Publicado: (2021)

The Formation of Glycan-Specific Natural Antibodies Repertoire in GalT-KO Mice Is Determined by Gut Microbiota
por: Bello-Gil, Daniel, et al.
Publicado: (2019)

Conversion of Tumors into Autologous Vaccines by Intratumoral Injection of α-Gal Glycolipids that Induce Anti-Gal/α-Gal Epitope Interaction
por: Galili, Uri
Publicado: (2011)

Distribution of the Galβ1-4Gal Epitope among Birds: Species-Specific Loss of the Glycan Structure in Chicken and Its Relatives
por: Suzuki, Noriko, et al.
Publicado: (2013)

Course of IgE to α‐Gal in a Swedish population of α‐Gal syndrome patients
por: Apostolovic, Danijela, et al.
Publicado: (2021)

Role of Truncated O-GalNAc Glycans in Cancer Progression and Metastasis in Endocrine Cancers
por: Pinto, Diluka, et al.
Publicado: (2023)

Antibody production and tolerance to the α-gal epitope as models for understanding and preventing the immune response to incompatible ABO carbohydrate antigens and for α-gal therapies
por: Galili, Uri
Publicado: (2023)

Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)
por: Vaz-Rodrigues, Rita, et al.
Publicado: (2022)

Abundant human anti-Galα3Gal antibodies display broad pathogen reactivity
por: Bernth Jensen, Jens Magnus, et al.
Publicado: (2020)

Host or pathogen-related factors in COVID-19 severity?
por: Gortázar, Christian, et al.
Publicado: (2020)

IgE, α-Gal and atherosclerosis
por: Wilson, Jeffrey M., et al.
Publicado: (2019)

Acceleration of Wound Healing by α-gal Nanoparticles Interacting with the Natural Anti-Gal Antibody
por: Galili, Uri
Publicado: (2015)

Update on possible animal sources for COVID‐19 in humans
por: Opriessnig, Tanja, et al.
Publicado: (2020)

L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells
por: Hoja-Łukowicz, Dorota, et al.
Publicado: (2012)

Comparative Genomics of Field Isolates of Mycobacterium bovis and M. caprae Provides Evidence for Possible Correlates with Bacterial Viability and Virulence
por: de la Fuente, José, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5unlrkv5hv3lvvhrsl118lhbim